Phathom Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.83 | -100% |
| P/S |
|
691.88 | 33.77 | 1949.03% |
|
|
| P/BV |
|
-6.49 | 4.83 | -234.32% |
|
|
| P/FCF |
|
-6.36 | 61 | -110.43% |
|
|
| Ev/Ebitda |
|
-1.44 | -22.17 | -93.49% |
|
|
| Ev/S |
|
336.51 | 22.57 | 1390.76% |
|
|
| Ev/FCF |
|
-1.65 | 68.76 | -102.4% |
|
|
| E/P |
|
-0.2276 | 0.0178 | -1380.54% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-23320.97 | 4.97 | -469139.48% | -11660.48 | +100% |
| ROE |
|
277.07 | 9.61 | 2782.65% |
|
|
| ROA |
|
-48.71 | 0.3443 | -14249.88% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-29558.94 | -25.17 | 117337.08% |
|
|
| ROCE |
|
219.39 | 15.45 | 1320.03% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.8712 | -3.68 | -76.3% | -0.7593 | +14.75% |
| Nеt Debt/Ebitda |
|
1.52 | -3.44 | -144.33% |
|
|
| Debt/Ratio |
|
0.3348 | 0.1986 | 68.61% |
|
|
| Debt/Equity |
|
0.8634 | 1.66 | -48.06% |
|
|
| Debt/Net Income |
|
-0.6874 | 10.32 | -106.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-36.62 | -90.94 | -59.73% | ||
| Growth impulse Net Income in 5 years |
|
-20.98 | -97.8 | -78.55% | ||
| Growth impulse FCF in 5 years |
|
125.41 | -108.72 | -215.35% | ||
| Growth impulse EPS in 5 years |
|
-82.49 | -142.05 | -41.93% |
IP Score
3.43/10
